Ganglioglioma in children and young adults: single institution experience and review of the literature

Background Ganglioglioma (GG) is a rare mixed glial-neuronal neoplasm accounting for 0.5–5% of all pediatric central nervous system (CNS) tumors. Rarity of this tumor has precluded defining robust treatment guidelines. This retrospective study evaluates the prognostic factors and outcomes of this rare neoplasm.